Finnish diagnostic company ArcDia is developing a test for COVID-19, for the use of healthcare. ArcDia has developed apparatus for diagnosing different infections for example respiratory infectious diseases, and the
Nordic Life Science
NLS Pharma News
Pharma
The first day of trading on Nasdaq Stockholm’s main market is 27 March 2020. March 18, 2020 that Nasdaq Stockholm’s listing committee had approved that the company’s shares are admitted
Lynparza has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of germline BRCA-mutated (gBRCAm) curatively unresectable pancreatic cancer. Lynparza is co-developed and co-commercialised with MSD. “Japan
Medicortex Finland has announced the start of a clinical trial for detection of mild Traumatic Brain Injury (TBI) and concussion. The clinical trial will be conducted at Satasairaala hospital in
Cantargia has announced the acquisition of a patent portfolio from Cellerant Therapeutics Inc covering aspects around the interleukin 1 receptor accessory protein (IL1RAP). The acquired IP includes a US patent
Cinclus Pharma has completed a financing round of SEK 250 million to fund the further clinical development of X842, a clinical-stage drug candidate for the treatment of gastroesophageal reflux disease
Clinical trials
Data from the first dose group in the SpagoPix phase I trial show that SN132D is well tolerated, and provide
Moberg Pharma have announced that all patients in the European MOB-015 Phase 3 study have completed their last study visit.
Oncopeptides has announced measures the company is taking in response to the global spread of the novel coronavirus (COVID-19) pandemic.
Medicortex Finland has announced the start of a clinical trial for detection of mild Traumatic Brain Injury (TBI) and concussion.
Gedea Biotech, has reported results from a clinical study of its lead product, pHyph, a vaginal tablet for topical treatment
Targovax has completed patient enrollment in the phase I trial with ONCOS-102 in combination with Keytruda in patients with advanced
As a precautionary measure, in the continuous efforts to limit the spreading of the COVID-19 outbreak, and to shelter patients
Medivir has presented new data from the completed phase Ia study with MIV-818. The primary objective of the phase Ia
Herantis Pharma has announced the results from the ongoing Phase 1-2 clinical trial examining its neuroprotective factor and novel drug
Initial analysis from an international clinical trial has indicated that the investigational drugs didn’t slow memory loss, cognitive decline in
InDex Pharmaceuticals has announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation
Scandinavian Biopharma has been awarded a 10.6 million EUR grant from EDCTP in international competition for the planned Phase III
Ascelia Pharma has announced that the first patient has been enrolled in the company’s global Phase III clinical study SPARKLE
Elypta has enrolled the first patient in the multi-center AURORAX-087A (AUR87A) study involving its novel liquid biopsy platform. This was
Immunicum has announced updated results from the randomized Phase II MERECA trial testing its off-the-shelf immune primer ilixadencel in combination
Follicum has received approval from the German Medicines Agency (BfArM) and the German Ethics Committee to start a Phase IIa
Profiles in Pharma
BioArctic’s lead compound has the potential to become the first disease-modifying treatment for Alzheimer’s, and so far the company’s journey
Few companies are as synonymous with Sweden as AstraZeneca and few CEOs as visible. Yet, Katarina Ageborg, AstraZeneca Sweden’s new
She joined LEO Pharma by chance, more than 27 years ago, but she remained there, for the true focus on
“It is with great regret and sadness we announce this very tragic and unexpected information,” says the Board of Directors,
In an interview in Nordic Life Science, the Head of AstraZeneca’s Oncology Business unit, shared his insights on current drug
Ironically, there is less serendipity in the success Saeid Esmaeilzadeh and Ashkan Pouya have achieved as business-makers than there is
Logistics
The best pharmaceuticals and medical supplies on the market are useless to patients unless they arrive at their destinations intact, unspoiled and on time. The proper packaging and shipping of
Two global life science firms share some of their projects and logistical solutions to deliver healthcare to parts of the world where it is needed the most. Cardiovascular disease is